Coronavirus LIVE Updates: Serum Institute of India Gets DCGI Nod to Resume Clinical Trial of AstraZeneca Vaccine; Time to Stop Looking for Unicorns, Warns WHO - Coronavirus Updates

Coronavirus LIVE Updates: Drugs Controller General of India (DCGI) Dr VG Somani has given permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.

Read More >>